Santala M, Risteli J, Risteli L, Puistola U, Kacinski B M, Stanley E R, Kauppila A
Department of Obstetrics and Gynaecology, University of Oulu, Finland.
Br J Cancer. 1998 Jun;77(11):1825-31. doi: 10.1038/bjc.1998.303.
The synthesis and degradation of type I and type III interstitial collagens releases several antigenic metabolites, whose measurement allows the metabolism of connective tissue to be evaluated under a variety of different conditions. In this study we investigated the influence of benign and malignant ovarian neoplasms on the metabolism of these collagens. The study population comprised patients with benign (n = 53), borderline (n = 6) or malignant (n = 36) ovarian neoplasms. We quantified the serum, cyst fluid and peritoneal/ascitic fluid concentrations of the amino-terminal propeptide of type I (PINP) and III (PIIINP) procollagens, indicators of the synthesis of type I and III collagen, respectively and the cross-linked carboxy-terminal telopeptide of type I collagen (ICTP), an indicator of type I collagen degradation. Macrophage colony-stimulating factor 1 (CSF-1) concentration was also assayed as its serum level is increased in ovarian cancer and CSF-1 may be involved in the regulation of collagen metabolism. The concentration of each antigen was significantly higher in patients with malignant tumour than with benign neoplasm in each comparison, except for ICTP in peritoneal fluid and for CSF-1 in cyst fluid. The high ascitic fluid concentration of PINP, PIIINP or CSF-1 correlated with malignancy, and the low cyst fluid concentration of any of the four markers was indicative of benign tumour. Levels of CSF-1 did not correlate with the levels of any of the markers of collagen turnover. The concentration of PINP in ascites was about 50 times higher and in cyst fluid about eight times higher than that in the serum from patients with malignant tumour, whereas the respective ratios for ICTP were only 2.5 and 1.3. In such patients, the ratio of ascitic fluid to serum concentration was also about 80-fold higher for PIIINP and about 20-fold higher for PINP than for ICTP. The different distributions of PIIINP, PINP and ICTP suggests dominance of synthetic processes or retarded elimination of PIIINP and PINP in ovarian cancer. In advanced malignancies, the accumulation of PINP and PIIINP in abdominal space, possibly due to increased synthesis and/or failed resorption, may promote ascites formation. This study shows that both accelerated synthesis and breakdown of fibrillar collagens are characteristic of ovarian malignancy, and suggests that measurements of cyst fluid or ascitic fluid concentrations of collagen metabolites or CSF-1 could be used in the differential diagnosis of benign and malignant ovarian neoplasms.
I型和III型间质胶原的合成与降解会释放出几种具有抗原性的代谢产物,对这些代谢产物进行检测能够在多种不同条件下评估结缔组织的代谢情况。在本研究中,我们调查了良性和恶性卵巢肿瘤对这些胶原代谢的影响。研究人群包括患有良性(n = 53)、交界性(n = 6)或恶性(n = 36)卵巢肿瘤的患者。我们分别对I型前胶原(PINP)和III型前胶原(PIIINP)氨基端前肽的血清、囊肿液和腹膜/腹水浓度进行了定量,它们分别是I型和III型胶原合成的指标,同时还对I型胶原的交联羧基端肽(ICTP)进行了定量,它是I型胶原降解的指标。还检测了巨噬细胞集落刺激因子1(CSF - 1)的浓度,因为其血清水平在卵巢癌中会升高,且CSF - 1可能参与胶原代谢的调节。在每次比较中,除了腹膜液中的ICTP和囊肿液中的CSF - 1外,恶性肿瘤患者每种抗原的浓度均显著高于良性肿瘤患者。腹水液中PINP、PIIINP或CSF - 1的高浓度与恶性肿瘤相关,四种标志物中任何一种在囊肿液中的低浓度都表明是良性肿瘤。CSF - 1的水平与任何胶原周转标志物的水平均无相关性。恶性肿瘤患者腹水中PINP的浓度比血清中高约50倍,囊肿液中高约8倍,而ICTP的相应比值分别仅为2.5和1.3。在这类患者中,腹水液与血清浓度的比值对于PIIINP也比ICTP高约80倍,对于PINP高约20倍。PIIINP、PINP和ICTP的不同分布表明在卵巢癌中合成过程占主导或PIIINP和PINP的清除受阻。在晚期恶性肿瘤中,PINP和PIIINP在腹腔内的积聚,可能是由于合成增加和/或吸收失败,可能会促进腹水形成。本研究表明,纤维状胶原的合成加速和分解加速都是卵巢恶性肿瘤的特征,并提示检测囊肿液或腹水液中胶原代谢产物或CSF - 1的浓度可用于卵巢良恶性肿瘤的鉴别诊断。